Imbria Pharmaceuticals logo

Imbria Pharmaceuticals Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Imbria Pharmaceuticals is a privately held clinical-stage biotechnology company based in Framingham, Massachusetts, focused on developing therapies for life-altering cardiometabolic disorders by improving cellular energy production in cardiovascular disease. Its lead candidate, ninerafaxstat, is in Phase 2 trials across three indications: nHCM, stable angina, and HFpEF, reflecting an approach that targets energetic impairment as a driver of symptoms and functional deficits. The company’s work sits at the intersection of cardiovascular medicine and cellular energetics, aiming to restore or enhance the heart’s energy production to improve patient outcomes.

Within the biotechnology research industry, Imbria pursues a focused clinical program that seeks to address energy metabolism in heart disease rather than broader disease categories. A notable development occurred in October 2025, when Imbria announced a partnership with the Hypertrophic Cardiomyopathy Association to advance research and patient engagement related to hypertrophic cardiomyopathy.

Find Imbria Pharmaceuticals employees' phone numbers or email addresses

Imbria Pharmaceuticals Global Highlights

Location
Employees

North America
9

Minus sign iconPlus sign icon
  • United States Of America
    9

Europe
2

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    2

Asia
1

Minus sign iconPlus sign icon
  • India
    1

Imbria Pharmaceuticals's Leadership

  • Owner at Imbria Pharmaceuticals
    M. F.
    Owner
  • Member Board Of Directors at Imbria Pharmaceuticals
    C. D.
    Member Board Of Directors
  • Board Member at Imbria Pharmaceuticals
    Z. A. B.
    Board Member

Imbria Pharmaceuticals Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Community & Social Services
  • Consultant
  • Entrepreneurship
  • Legal
  • Other
  • Pharmaceuticals

Contact profiles from Imbria Pharmaceuticals

Name
Title
Contact
Location
Last Update
  • Owner at Imbria Pharmaceuticals
    M. F.
    Owner
    Oct 17, 2024
  • Member Board Of Directors at Imbria Pharmaceuticals
    C. D.
    Member Board Of Directors
    United Kingdom
    Aug 18, 2026
  • Board Member at Imbria Pharmaceuticals
    Z. A. B.
    Board Member
    United Kingdom
    Sep 09, 2026

Frequently Asked Questions

What is Imbria Pharmaceuticals known for?

Minus sign iconPlus sign icon
Imbria Pharmaceuticals was founded in 2018 and operates in the Biotechnology Research industry. Explore Imbria Pharmaceuticals's company overview page for more information.

What is Imbria Pharmaceuticals's most common email format?

Minus sign iconPlus sign icon
Imbria Pharmaceuticals employees' email format typically follows the pattern of FL@imbria.com. Trying to find reliable and up-to-date employee contact data? Find more Imbria Pharmaceuticals email formats with LeadIQ.

How many employees does Imbria Pharmaceuticals have currently?

Minus sign iconPlus sign icon
Imbria Pharmaceuticals has approximately 16 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Imbria Pharmaceuticals's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Imbria Pharmaceuticals's key employees include:

  • Owner: M. F.
  • Member Board Of Directors: C. D.
  • Board Member: Z. A. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.